Healthy volunteers help validate new blood tests for cancer detection
NCT ID NCT07663994
First seen Jun 24, 2026 · Last updated Jul 24, 2026 · Updated 3 times
Summary
This study enrolls 68 healthy volunteers (cancer-free adults working at a French hospital) to help validate new blood-based DNA analysis methods. Participants give one blood sample, which is tested for cancer-related genetic mutations using advanced sequencing and PCR techniques. The goal is to confirm that these tests correctly identify people without cancer, laying groundwork for future early detection tools.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help develop more accurate blood tests to detect cancer early in healthy people.
- What could go wrong
- This is a small, early-stage validation study in healthy volunteers, not a treatment trial. The methods may not prove reliable enough for widespread use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS (CANCER) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institut Universitaire du Cancer de Toulouse - Oncopole
RECRUITINGToulouse, 31059, France